95 related articles for article (PubMed ID: 16941649)
1. Decline of striatal dopamine release in parkin-deficient mice shown by ex vivo autoradiography.
Sato S; Chiba T; Nishiyama S; Kakiuchi T; Tsukada H; Hatano T; Fukuda T; Yasoshima Y; Kai N; Kobayashi K; Mizuno Y; Tanaka K; Hattori N
J Neurosci Res; 2006 Nov; 84(6):1350-7. PubMed ID: 16941649
[TBL] [Abstract][Full Text] [Related]
2. Impaired in vivo dopamine release in parkin knockout mice.
Oyama G; Yoshimi K; Natori S; Chikaoka Y; Ren YR; Funayama M; Shimo Y; Takahashi R; Nakazato T; Kitazawa S; Hattori N
Brain Res; 2010 Sep; 1352():214-22. PubMed ID: 20620130
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice.
Casarejos MJ; Solano RM; Menéndez J; Rodríguez-Navarro JA; Correa C; García de Yébenes J; Mena MA
J Neurochem; 2005 Aug; 94(4):1005-14. PubMed ID: 16000163
[TBL] [Abstract][Full Text] [Related]
4. Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity.
Perez FA; Curtis WR; Palmiter RD
BMC Neurosci; 2005 Dec; 6():71. PubMed ID: 16375772
[TBL] [Abstract][Full Text] [Related]
5. Pael receptor is involved in dopamine metabolism in the nigrostriatal system.
Imai Y; Inoue H; Kataoka A; Hua-Qin W; Masuda M; Ikeda T; Tsukita K; Soda M; Kodama T; Fuwa T; Honda Y; Kaneko S; Matsumoto S; Wakamatsu K; Ito S; Miura M; Aosaki T; Itohara S; Takahashi R
Neurosci Res; 2007 Dec; 59(4):413-25. PubMed ID: 17889953
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D(1) and D(2) receptors in the forebrain of dystonia musculorum mutant mice: an autoradiographic survey in relation to dopamine contents.
Ongali B; Ase AR; Hébert C; Amdiss F; Reader TA
Synapse; 2000 Jul; 37(1):1-15. PubMed ID: 10842346
[TBL] [Abstract][Full Text] [Related]
7. Effect of sensory stimulus on striatal dopamine release in humans and cats: a [(11)C]raclopride PET study.
Thobois S; Hassoun W; Ginovart N; Garcia-Larrea L; Le Cavorsin M; Guillouet S; Bonnefoi F; Costes N; Lavenne F; Broussolle E; Leviel V
Neurosci Lett; 2004 Sep; 368(1):46-51. PubMed ID: 15342132
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations.
Joyce JN; Renish L; Osredkar T; Walro JM; Kucera J; Dluzen DE
Synapse; 2004 Apr; 52(1):11-9. PubMed ID: 14755628
[TBL] [Abstract][Full Text] [Related]
9. Pael-R transgenic mice crossed with parkin deficient mice displayed progressive and selective catecholaminergic neuronal loss.
Wang HQ; Imai Y; Inoue H; Kataoka A; Iita S; Nukina N; Takahashi R
J Neurochem; 2008 Oct; 107(1):171-85. PubMed ID: 18691389
[TBL] [Abstract][Full Text] [Related]
10. Impaired dopamine release and synaptic plasticity in the striatum of parkin-/- mice.
Kitada T; Pisani A; Karouani M; Haburcak M; Martella G; Tscherter A; Platania P; Wu B; Pothos EN; Shen J
J Neurochem; 2009 Jul; 110(2):613-21. PubMed ID: 19457102
[TBL] [Abstract][Full Text] [Related]
11. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
Okauchi T; Suhara T; Maeda J; Kawabe K; Obayashi S; Suzuki K
Synapse; 2001 Aug; 41(2):87-95. PubMed ID: 11400175
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation enhances stimulant-induced striatal dopamine elevation.
Petrulli JR; Kalish B; Nabulsi NB; Huang Y; Hannestad J; Morris ED
Transl Psychiatry; 2017 Mar; 7(3):e1076. PubMed ID: 28350401
[TBL] [Abstract][Full Text] [Related]
13. Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([11C] raclopride) and in-vitro ([3H] spiperone) autoradiography.
Thanos PK; Michaelides M; Piyis YK; Wang GJ; Volkow ND
Synapse; 2008 Jan; 62(1):50-61. PubMed ID: 17960763
[TBL] [Abstract][Full Text] [Related]
14. Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: comparison with results in vivo.
Minuzzi L; Olsen AK; Bender D; Arnfred S; Grant R; Danielsen EH; Cumming P
Synapse; 2006 Mar; 59(4):211-9. PubMed ID: 16385509
[TBL] [Abstract][Full Text] [Related]
15. Endogenous dopamine release after pharmacological challenges in Parkinson's disease.
Piccini P; Pavese N; Brooks DJ
Ann Neurol; 2003 May; 53(5):647-53. PubMed ID: 12730999
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of dopamine D2 receptors in dopaminergic drug-naive patients with Parkin gene mutations.
Scherfler C; Khan NL; Pavese N; Lees AJ; Quinn NP; Brooks DJ; Piccini PP
Mov Disord; 2006 Jun; 21(6):783-8. PubMed ID: 16511856
[TBL] [Abstract][Full Text] [Related]
17. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
[TBL] [Abstract][Full Text] [Related]
18. Effect of the neurotoxic dose of methamphetamine on gene expression of parkin and Pael-receptors in rat striatum.
Nakahara T; Kuroki T; Ohta E; Kajihata T; Yamada H; Yamanaka M; Hashimoto K; Tsutsumi T; Hirano M; Uchimura H
Parkinsonism Relat Disord; 2003 Mar; 9(4):213-9. PubMed ID: 12618056
[TBL] [Abstract][Full Text] [Related]
19. Age-related changes of dopamine D1-like and D2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography.
Suzuki M; Hatano K; Sakiyama Y; Kawasumi Y; Kato T; Ito K
Synapse; 2001 Sep; 41(4):285-93. PubMed ID: 11494399
[TBL] [Abstract][Full Text] [Related]
20. Midbrain neuronal cultures from parkin mutant mice are resistant to nitric oxide-induced toxicity.
Solano RM; Menéndez J; Casarejos MJ; Rodríguez-Navarro JA; García de Yébenes J; Mena MA
Neuropharmacology; 2006 Aug; 51(2):327-40. PubMed ID: 16701721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
